For Japanese Companies

  • EU/US Market Assessment
  • EU/US Market Entry Strategy
  • Partner Identification / Licensing
  • Local Representation
  • EU/US Regulatory and Clinical Strategy
  • Funding Solutions
Beginning with the Nordic Countries Aurora Partners can help you assess the overall EU market and US market, and getting feedback on the viability of your product.
There are several modes of entering the EU and US markets and we can layout the options, advising you on the best approach.
Whether you need to find a distributor, licensor/licensee or JV/M&A company in the Nordic or other EU countries or US, we support from initial screening of candidates, arrangement of meetings, and right through the negotiating and contracting stages.
Aurora Partners can act as your representative in the EU/US countries to sell your products/services or manage relationships with existing partners including CROs for development of your product.
It is critical to understand the regulatory and clinical pathway in order to maximise the value of your product, whether you plan to license it out or bring to market yourself. Aurora Partners can develop the pathway to NDA approval and manage interactions with the Japanese regulatory authorities.
As part of getting access to EU/US markets, we can assist in evaluating capital solutions, including Venture Capital and Private Equity.

For Companies Wanting to Do Business in Japan

  • Japan Market Assessment
  • Japan Market Entry Strategy
  • Partner Identification / Licensing
  • Japan Local Representation
  • Japan Regulatory and Clinical Strategy
  • Funding Solutions
Aurora Partners help you assess the market and get feedback on the viability of your product.
There are several modes of entering Japan and we can layout the options, advising you on the best approach.
To find a distributor, licensor/licensee or JV/M&A company in Japan, Aurora Partners support from initial screening of candidates, arrangement of meetings, right through the negotiating and contracting stages.
Aurora Partners can act as your representative in Japan to sell your products/services, manage relationships with existing partners including CROs for development of your product.
It is critical to understand the regulatory and clinical pathway in order to maximise the value of your product, whether you plan to license it out or bring to market yourself. Aurora Partners can develop the pathway to NDA approval and manage interactions with the Japanese regulatory authorities.
As part of strengthening relationships with Japan, we can assist in evaluating various capital solutions including venture capital and private equity.